301377.SZ
鼎泰高科
SZSE · C 制造业 · CN
CNY 393.01
−5.64%Year over year
Reported trailing growth
- Revenue
- +51.7%
- EBITDA
- —
- EBIT
- +138.0%
- EPS
- +139.7%
- Free cash flow
- —
- Operating cash flow
- +2.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +20.7%
- EBITDA
- +24.7%
- EBIT
- +25.9%
- Net income
- +24.8%
- EPS
- +20.2%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026